EdgarLookup

Sofgen Pharma S.A. — All Filings

168 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 15-12G 20-F 20-F/A 20FR12B 25-NSE 3 424B3 425 6-K 8-A12B CERT CORRESP EFFECT F-1 F-4 F-4/A NT 20-F POS AM RW SC 13D SC 13D/A SC 13G SCHEDULE 13D SCHEDULE 13D/A UPLOAD
Form Description Accession Number Filed Period
3 0001213900-26-034772 Mar 26, 2026 Mar 18, 2026
3 0001213900-26-034776 Mar 26, 2026 Mar 18, 2026
3 0001213900-26-031547 Mar 19, 2026 Mar 18, 2026
3 0001213900-26-030584 Mar 18, 2026
3 0001213900-26-030582 Mar 18, 2026
20-F ANNUAL REPORT 0001213900-26-028293 Mar 16, 2026 Dec 31, 2024
15-12G FORM 15-12G 0001213900-26-028339 Mar 16, 2026
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-118714 Dec 5, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-112342 Nov 19, 2025
20-F 20-F 0001628280-25-041512 Sep 3, 2025 Dec 31, 2023
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-070719 Aug 1, 2025
25-NSE 0001354457-25-000715 Jul 21, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-063804 Jul 14, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-042301 May 13, 2025
NT 20-F NOTIFICATION OF LATE FILING 0001213900-25-038561 May 1, 2025 Dec 31, 2024
SCHEDULE 13D 0001104659-25-040275 Apr 28, 2025
SCHEDULE 13D 0001104659-25-039600 Apr 25, 2025
SCHEDULE 13D 0001213900-25-034049 Apr 22, 2025
SCHEDULE 13D 0001213900-25-034047 Apr 22, 2025
SCHEDULE 13D/A 0001213900-25-032715 Apr 16, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-031270 Apr 14, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-030333 Apr 9, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001013762-25-002205 Mar 25, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-020912 Mar 6, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-015065 Feb 19, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-009141 Feb 3, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-004705 Jan 21, 2025 Jan 17, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-004017 Jan 16, 2025
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-000776 Jan 3, 2025
6-K 6-K 0001213900-24-113641 Dec 31, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-111262 Dec 20, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000338 Dec 3, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-105118 Dec 3, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-103790 Nov 29, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-099202 Nov 15, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-093539 Nov 1, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000305 Oct 29, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000303 Oct 28, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-086965 Oct 10, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000293 Oct 10, 2024
6-K 6-K 0001213900-24-086325 Oct 8, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000289 Sep 19, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-079621 Sep 18, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000274 Sep 4, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-074773 Sep 3, 2024
6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-24-072414 Aug 26, 2024
SC 13D/A 0001019056-24-000253 Aug 23, 2024
SC 13D/A SCHEDULE 13D/A 0001019056-24-000235 Aug 12, 2024
SC 13D/A AMENDMENT 0001019056-24-000231 Aug 8, 2024
SC 13D/A SC 13D/A 0001019056-24-000215 Jul 29, 2024